Reducing diagnostic uncertainty to improve treatment of respiratory infections

Affiliations

¹ Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City, UT 84108, USA. Electronic address: andy.pavia@hsc.utah.edu.

Comment

Andrew T Pavia. Lancet Respir Med. 2017 May.

. 2017 May;5(5):364-365.

doi: 10.1016/S2213-2600(17)30126-1. Epub 2017 Apr 6.

¹ Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City, UT 84108, USA. Electronic address: andy.pavia@hsc.utah.edu.

No abstract available

Comment on

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial.
Brendish NJ, Malachira AK, Armstrong L, Houghton R, Aitken S, Nyimbili E, Ewings S, Lillie PJ, Clark TW. Brendish NJ, et al. Lancet Respir Med. 2017 May;5(5):401-411. doi: 10.1016/S2213-2600(17)30120-0. Epub 2017 Apr 6. Lancet Respir Med. 2017. PMID: 28392237 Free PMC article. Clinical Trial.